Herceptin (trastuzumab) is a prescription drug that’s used to treat certain types of breast cancer and stomach cancer. Herceptin can cause side effects that range from mild to serious.

The National Agency for Food and Drug Administration and Control (NAFDAC) has raised a public health alert over the circulation ...

Herceptin’s average sales price (ASP) declined 21% between second-quarter 2019 and second-quarter 2022. The five biosimilar entrants not only entered with lower price points, but within three years, ...

By 2022 they had developed one that linked Herceptin to another cancer-killing drug. This therapy, for the first time, could damage tumors that had vanishingly low levels of HER2.

Targeted Therapy: Herceptin. Trastuzumab (Herceptin) was the first targeted therapy approved by the FDA for HER2+ breast cancer. It’s a type of biologic drug called a monoclonal antibody.

Meanwhile, Roche, the Swiss makers of the drug said that they had read The Lancet article, but did not agree with it. The journal said that Herceptin caused heart failure in the women who used it.

Health AffairsVol. 42, No. 6: Medicaid, Drug Pricing, Aging & More Cancer Drug Trastuzumab And Its Biosimilars Compete On Price For Market Share Alice J. Chen , ...

Herceptin’s US sales were just over $2.9 billion last year, ... But as they are biologic drugs manufactured in cells there may be some slight differences compared with the reference product.

SAN ANTONIO — Fam-trastuzumab deruxtecan-nxki improved outcomes compared with capecitabine-based regimens as third-line treatment for certain patients with HER2-positive metastatic breast cancer ...